208 related articles for article (PubMed ID: 19047147)
1. Differential p53 engagement in response to oxidative and oncogenic stresses in Fanconi anemia mice.
Rani R; Li J; Pang Q
Cancer Res; 2008 Dec; 68(23):9693-702. PubMed ID: 19047147
[TBL] [Abstract][Full Text] [Related]
2. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
Li X; Wu L; Zopp M; Kopelov S; Du W
Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
[TBL] [Abstract][Full Text] [Related]
3. Persistent response of Fanconi anemia haematopoietic stem and progenitor cells to oxidative stress.
Li Y; Amarachintha S; Wilson AF; Li X; Du W
Cell Cycle; 2017 Jun; 16(12):1201-1209. PubMed ID: 28475398
[TBL] [Abstract][Full Text] [Related]
4. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
5. The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Du W; Amarachintha S; Erden O; Wilson A; Pang Q
Oncotarget; 2016 Sep; 7(37):60005-60020. PubMed ID: 27507053
[TBL] [Abstract][Full Text] [Related]
6. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
[TBL] [Abstract][Full Text] [Related]
7. Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.
Li X; Wilson AF; Du W; Pang Q
Stem Cell Reports; 2018 Feb; 10(2):339-346. PubMed ID: 29307578
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
9. An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation.
Marion W; Boettcher S; Ruiz-Torres S; Lummertz da Rocha E; Lundin V; Morris V; Chou S; Zhao AM; Kubaczka C; Aumais O; Zhang Y; Shimamura A; Schlaeger TM; North TE; Ebert BL; Wells SI; Daley GQ; Rowe RG
Blood Adv; 2020 Oct; 4(19):4679-4692. PubMed ID: 33002135
[TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia links reactive oxygen species to insulin resistance and obesity.
Li J; Sipple J; Maynard S; Mehta PA; Rose SR; Davies SM; Pang Q
Antioxid Redox Signal; 2012 Oct; 17(8):1083-98. PubMed ID: 22482891
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins.
Park SJ; Ciccone SL; Beck BD; Hwang B; Freie B; Clapp DW; Lee SH
J Biol Chem; 2004 Jul; 279(29):30053-9. PubMed ID: 15138265
[TBL] [Abstract][Full Text] [Related]
12. Compromised repair of radiation-induced DNA double-strand breaks in Fanconi anemia fibroblasts in G2.
Zahnreich S; Weber B; Rösch G; Schindler D; Schmidberger H
DNA Repair (Amst); 2020 Dec; 96():102992. PubMed ID: 33069004
[TBL] [Abstract][Full Text] [Related]
13. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Fanca or Fancd2 dysregulates Treg in mice.
Du W; Erden O; Wilson A; Sipple JM; Schick J; Mehta P; Myers KC; Steinbrecher KA; Davies SM; Pang Q
Blood; 2014 Mar; 123(12):1938-47. PubMed ID: 24501220
[TBL] [Abstract][Full Text] [Related]
15. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
Zhu W; Dutta A
Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
[TBL] [Abstract][Full Text] [Related]
16. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
[TBL] [Abstract][Full Text] [Related]
17. Changes in vimentin, lamin A/C and mitofilin induce aberrant cell organization in fibroblasts from Fanconi anemia complementation group A (FA-A) patients.
Capanni C; Bruschi M; Columbaro M; Cuccarolo P; Ravera S; Dufour C; Candiano G; Petretto A; Degan P; Cappelli E
Biochimie; 2013 Oct; 95(10):1838-47. PubMed ID: 23831462
[TBL] [Abstract][Full Text] [Related]
18. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
[TBL] [Abstract][Full Text] [Related]
19. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.
Zhang X; Sejas DP; Qiu Y; Williams DA; Pang Q
J Cell Sci; 2007 May; 120(Pt 9):1572-83. PubMed ID: 17405815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
